Thierry K.
- Country
- France
- Department
- néphrologie
Research Overview
- A Phase 3 open-label, controlled, randomised, multi-centre trial comparing imlifidase and standard-of-care with standard-of-care alone in the treatment of severe anti-GBM antibody disease (Goodpasture disease)
- Evaluation of Remission Maintenance with Extended Prednisone Administration in ANCA-Associated Vasculitis Using Rituximab Therapy
- Evaluation of Nicotinamide Efficacy and Tolerance in Patients with Persistent Acute Kidney Injury: A Randomized Double-Blind Controlled Trial
Data & Insights
Has run more than one trial at 6 of 75 partner sites.
Specializations
Autoimmune Vasculitis
This investigator specializes in treating complex autoimmune conditions, particularly focusing on systemic anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Their research encompasses both granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), with particular attention to remission maintenance strategies.
- ANCA-Associated Vasculitis Management
- Remission Maintenance Protocols
- Long-term Disease Control
The investigator explores innovative therapeutic approaches using immunosuppressive treatments for vasculitis control.
Renal Autoimmune Disorders
The investigator has developed expertise in treating severe kidney conditions, specifically anti-GBM antibody disease, also known as Goodpasture disease. Their work involves evaluating novel therapeutic interventions for improving kidney function in patients with aggressive autoimmune kidney disorders.
- Anti-GBM Disease Treatment
- Kidney Function Preservation
- Novel Therapeutic Approaches
Their research focuses on advancing treatment options for patients with severe autoimmune kidney conditions.
Immunotherapy Research
The investigator explores innovative immunological treatments, including rituximab therapy and novel immunological agents. Their work encompasses developing treatment protocols for various autoimmune conditions affecting multiple organ systems.
- Immunosuppressive Strategies
- Therapeutic Protocol Development
- Treatment Response Assessment
The research extends to evaluating treatment efficacy through standardized assessment tools and clinical outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.